Jing Li

机构：Lanzhou University Second Hospital, Lanzhou University · ORCID：0000-0003-4136-6204

发表论文 26 篇 · 总被引 511 次 · h-index 11

代表论文

• Phase 1 investigation of lenalidomide/rituximab plus outcomes of lenalidomide maintenance in relapsed CNS lymphoma (2018 · Blood Advances · 被引 194)
• Identification of Frailty and Its Risk Factors in Elderly Hospitalized Patients from Different Wards: A Cross-Sectional Study in China (2019 · Clinical Interventions in Aging · 被引 81)
• Differences and similarities in clinical pharmacy practice in China and the United States: a narrative review (2017 · European Journal of Hospital Pharmacy · 被引 40)
• Role of frailty in predicting outcomes after stroke: a systematic review and meta-analysis (2024 · Frontiers in Psychiatry · 被引 32)
• The bidirectional relationship between activities of daily living and frailty during short-and long-term follow-up period among the middle-aged and older population: findings from the Chinese nationwide cohort study (2024 · Frontiers in Public Health · 被引 26)
• The Role and Therapeutic Perspectives of Sirtuin 3 in Cancer Metabolism Reprogramming, Metastasis, and Chemoresistance (2022 · Frontiers in Oncology · 被引 26)